What is it about?

The rewritten version is somewhat simplified but could still be made clearer for non-professionals. Here's a more straightforward version: Breast cancer (BC) is the most common cancer and a leading cause of death among women worldwide. Scientists have learned more about how tumors avoid the immune system, leading to new treatments like immunotherapy, monoclonal antibodies, cancer vaccines, and oncolytic viruses. These treatments show promise but still face challenges, such as tumors resisting the therapy or patients not responding well. This article explains the latest updates in breast cancer immunotherapy, including clinical trial results and treatments that are used alone or with traditional methods like chemotherapy or radiation.

Featured Image

Read the Original

This page is a summary of: Breast cancer immunotherapy: Realities and advances, Cancer Innovation, September 2024, Tsinghua University Press,
DOI: 10.1002/cai2.140.
You can read the full text:

Read

Contributors

The following have contributed to this page